🇺🇸
United States · US · US:0955-2900_63c52b96-0bdf-42f0-9c6c-e439846e6926
Insulin glargine U-300 Max
In shortageUNIISPLATC A10AE04
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerSanofi-Aventis U.S. LLC
CountryUS (United States)
ATC codeA10AE04
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1109552900022 SYRINGE in 1 CARTON (0955-2900-02) / 3 mL in 1 SYRINGE (0955-2900-01)
Annotations
UNII (FDA Substance ID)
2ZM8CX04RZ
INSULIN GLARGINE
RxCUI 274783
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Insulin Lispro-aabc Injection
Raw payload (JSON)
{
"unii": {
"unii": "2ZM8CX04RZ",
"rxcui": "274783",
"inchikey": null,
"display_name": "INSULIN GLARGINE",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"5d9f0e10-edb9-4960-bd62-cf406e75bbe7": {
"match": "brand_token",
"title": "INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [REMEDYREPACK INC.]",
"spl_version": "9",
"published_date": "2026-04-08"
}
},
"productid": "0955-2900_63c52b96-0bdf-42f0-9c6c-e439846e6926",
"productndc": "0955-2900",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "INSULIN GLARGINE",
"shortage_reason": "Insulin Lispro-aabc Injection",
"shortage_status": "current",
"proprietary_name": "Insulin glargine U-300 Max",
"active_ingred_unit": "[iU]/mL",
"application_number": "BLA206538",
"marketing_category": "BLA",
"nonproprietary_name": "insulin glargine",
"start_marketing_date": "20230401",
"active_numerator_strength": "300"
}Related drugs
Other records sharing ATC code A10AE04.
Access this data programmatically
Query Insulin glargine U-300 Max and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.